Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
Completed
N/A
Interventional Study
Major Depressive Episode
Borderline Personality Disorder
Suicide
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 75
- Sponsor
- Massachusetts General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This neuroimaging study is a clinical trial investigating the effectiveness of intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) in reducing suicide risk in patients with major depressive episode (MDE) or borderline personality disorder (BPD).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18-65 years of age
* Diagnosed with BPD or MDE
* Chief complaint of suicidal thoughts and behaviors
Exclusion Criteria:
* Neurological conditions with known structural brain lesion
* Prior neurosurgical procedure
* Metal in the body that is ferromagnetic or metal injury to t…
Contacts
No contact information available.